| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
71,001 |
61,782 |
$4.31M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
55,098 |
50,181 |
$4.24M |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
19,665 |
6,868 |
$954K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,356 |
10,408 |
$904K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
11,795 |
9,892 |
$853K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,616 |
6,235 |
$525K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
11,186 |
9,960 |
$510K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,907 |
4,446 |
$491K |
| 99233 |
Prolong inpt eval add15 m |
5,156 |
1,965 |
$384K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
27,169 |
24,383 |
$383K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
2,929 |
2,671 |
$380K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14,706 |
13,290 |
$331K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22,572 |
20,595 |
$322K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,373 |
3,101 |
$298K |
| 99222 |
Initial hospital care, per day, moderate complexity |
3,296 |
2,768 |
$276K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,831 |
3,505 |
$273K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
4,424 |
3,987 |
$218K |
| 99223 |
Prolong inpt eval add15 m |
1,813 |
1,640 |
$212K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,040 |
2,755 |
$206K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,067 |
1,906 |
$206K |
| 36415 |
Collection of venous blood by venipuncture |
19,669 |
17,696 |
$142K |
| 99215 |
Prolong outpt/office vis |
1,222 |
1,094 |
$142K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,364 |
1,247 |
$110K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
1,225 |
1,158 |
$109K |
| 99239 |
Hospital discharge day management, more than 30 minutes |
1,406 |
1,268 |
$96K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,541 |
6,584 |
$87K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,291 |
2,132 |
$84K |
| 92551 |
|
7,249 |
6,719 |
$83K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
5,214 |
4,701 |
$83K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
6,932 |
5,236 |
$73K |
| 90686 |
|
6,123 |
5,703 |
$64K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,702 |
5,369 |
$64K |
| 90677 |
|
766 |
708 |
$58K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
6,314 |
5,055 |
$58K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
1,466 |
1,265 |
$49K |
| 99495 |
|
369 |
345 |
$49K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
4,728 |
3,940 |
$49K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,440 |
1,984 |
$48K |
| 99205 |
Prolong outpt/office vis |
305 |
272 |
$43K |
| 90670 |
|
5,428 |
4,902 |
$42K |
| 3008F |
|
1,868 |
1,698 |
$41K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
540 |
489 |
$39K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
795 |
729 |
$37K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,806 |
1,553 |
$32K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
971 |
866 |
$30K |
| 99460 |
|
434 |
401 |
$29K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
172 |
52 |
$26K |
| 99217 |
|
537 |
505 |
$24K |
| 99221 |
|
363 |
342 |
$23K |
| 90474 |
|
2,458 |
2,092 |
$19K |
| 99225 |
|
381 |
206 |
$17K |
| 99307 |
|
3,554 |
3,049 |
$17K |
| 90648 |
|
2,192 |
2,010 |
$17K |
| 99219 |
|
198 |
173 |
$16K |
| 81003 |
|
1,819 |
1,549 |
$16K |
| 99220 |
|
125 |
118 |
$15K |
| 99173 |
|
2,842 |
2,628 |
$15K |
| 99383 |
|
167 |
158 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
427 |
391 |
$13K |
| 90723 |
|
2,135 |
1,922 |
$12K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
284 |
156 |
$9K |
| 90651 |
|
1,221 |
1,105 |
$9K |
| 99462 |
|
191 |
116 |
$9K |
| 87807 |
|
679 |
624 |
$9K |
| 82962 |
|
223 |
197 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
163 |
147 |
$8K |
| 90680 |
|
4,154 |
3,597 |
$7K |
| 96127 |
|
1,967 |
1,749 |
$7K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
84 |
83 |
$7K |
| 93000 |
|
991 |
918 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
201 |
187 |
$7K |
| 93016 |
|
439 |
427 |
$7K |
| 90671 |
|
1,088 |
950 |
$6K |
| 90473 |
|
534 |
502 |
$6K |
| 90715 |
|
920 |
827 |
$5K |
| 90656 |
|
705 |
678 |
$5K |
| 99381 |
|
82 |
74 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
65 |
57 |
$5K |
| 92567 |
|
165 |
151 |
$5K |
| 99384 |
|
50 |
46 |
$5K |
| 93018 |
|
440 |
427 |
$4K |
| 90633 |
|
3,065 |
2,749 |
$4K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
77 |
77 |
$4K |
| 81002 |
|
1,714 |
1,207 |
$4K |
| 81025 |
|
445 |
407 |
$3K |
| 99382 |
|
43 |
37 |
$3K |
| 0072A |
|
167 |
99 |
$3K |
| 99406 |
|
219 |
196 |
$3K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
70 |
65 |
$3K |
| 0071A |
|
142 |
92 |
$3K |
| 99177 |
|
670 |
632 |
$2K |
| 99218 |
|
29 |
27 |
$2K |
| 80305 |
|
15 |
15 |
$1K |
| 99188 |
|
70 |
64 |
$1K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
241 |
212 |
$1K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
554 |
469 |
$939.06 |
| 90688 |
|
29 |
28 |
$923.71 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
148 |
116 |
$897.32 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
100 |
69 |
$849.93 |
| 90647 |
|
1,301 |
1,162 |
$657.26 |
| 85018 |
|
159 |
157 |
$599.25 |
| 94760 |
|
631 |
531 |
$569.44 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
1,097 |
1,013 |
$562.59 |
| 3045F |
|
26 |
26 |
$388.35 |
| 90716 |
|
1,400 |
1,236 |
$368.88 |
| 90619 |
|
87 |
69 |
$357.60 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
111 |
93 |
$355.47 |
| 86308 |
|
64 |
56 |
$303.91 |
| 99305 |
|
23 |
13 |
$276.48 |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
12 |
12 |
$246.02 |
| 93244 |
|
12 |
12 |
$215.09 |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
19 |
16 |
$194.73 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
86 |
67 |
$155.40 |
| 99441 |
|
18 |
18 |
$152.59 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
15 |
15 |
$128.26 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
234 |
191 |
$102.28 |
| 95251 |
|
305 |
285 |
$90.40 |
| 90700 |
|
1,173 |
1,037 |
$85.44 |
| 90707 |
|
1,406 |
1,242 |
$51.78 |
| 36416 |
|
781 |
717 |
$27.42 |
| 96160 |
|
12 |
12 |
$20.72 |
| 90734 |
|
647 |
597 |
$13.20 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
36 |
30 |
$1.87 |
| 3051F |
|
93 |
89 |
$0.00 |
| 3046F |
|
42 |
38 |
$0.00 |
| 90461 |
|
37 |
27 |
$0.00 |
| 90710 |
|
1,054 |
913 |
$0.00 |
| 91308 |
|
15 |
13 |
$0.00 |
| 98960 |
|
29 |
29 |
$0.00 |
| 90696 |
|
1,139 |
1,001 |
$0.00 |
| 3044F |
|
232 |
222 |
$0.00 |
| 90698 |
|
739 |
641 |
$0.00 |
| 90697 |
|
146 |
142 |
$0.00 |
| 91307 |
|
147 |
86 |
$0.00 |
| 3052F |
|
52 |
49 |
$0.00 |
| 99318 |
|
14 |
13 |
$0.00 |